Ross JS - Search Results

1

Access to COVID-19 Vaccines in High-, Middle-, and Low-Income Countries Hosting Clinical Trials.

Ramachandran R, Ross JS, Miller JE. Ramachandran R, et al. Among authors: ross js. JAMA Netw Open. 2021 Nov 1;4(11):e2134233. doi: 10.1001/jamanetworkopen.2021.34233. JAMA Netw Open. 2021. PMID: 34792596 Free PMC article.

2

Use of health care services by lower-income and higher-income uninsured adults.

Ross JS, Bradley EH, Busch SH. Ross JS, et al. JAMA. 2006 May 3;295(17):2027-36. doi: 10.1001/jama.295.17.2027. JAMA. 2006. PMID: 16670411

3

Reporting of results in ClinicalTrials.gov and high-impact journals.

Becker JE, Krumholz HM, Ben-Josef G, Ross JS. Becker JE, et al. Among authors: ross js. JAMA. 2014 Mar 12;311(10):1063-5. doi: 10.1001/jama.2013.285634. JAMA. 2014. PMID: 24618969 Free PMC article. No abstract available.

4

Reporting of noninferiority trials in ClinicalTrials.gov and corresponding publications.

Gopal AD, Desai NR, Tse T, Ross JS. Gopal AD, et al. Among authors: ross js. JAMA. 2015 Mar 17;313(11):1163-5. doi: 10.1001/jama.2015.1697. JAMA. 2015. PMID: 25781447 Free PMC article. No abstract available.

5

Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.

Miller JE, Korn D, Ross JS. Miller JE, et al. Among authors: ross js. BMJ Open. 2015 Nov 12;5(11):e009758. doi: 10.1136/bmjopen-2015-009758. BMJ Open. 2015. PMID: 26563214 Free PMC article. Review.

6

The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.

Carlat DJ, Fagrelius T, Ramachandran R, Ross JS, Bergh S. Carlat DJ, et al. Among authors: ross js. BMC Med Educ. 2016 Aug 12;16(1):202. doi: 10.1186/s12909-016-0725-y. BMC Med Educ. 2016. PMID: 27519253 Free PMC article.

7

Open Access Platforms for Sharing Clinical Trial Data.

Ross JS, Krumholz HM. Ross JS, et al. JAMA. 2016 Aug 9;316(6):666. doi: 10.1001/jama.2016.8794. JAMA. 2016. PMID: 27532929 No abstract available.

8

Association of the FDA Amendment Act with trial registration, publication, and outcome reporting.

Phillips AT, Desai NR, Krumholz HM, Zou CX, Miller JE, Ross JS. Phillips AT, et al. Among authors: ross js. Trials. 2017 Jul 18;18(1):333. doi: 10.1186/s13063-017-2068-3. Trials. 2017. PMID: 28720112 Free PMC article. Review.

9

Characterizing expanded access and compassionate use programs for experimental drugs.

Miller JE, Ross JS, Moch KI, Caplan AL. Miller JE, et al. Among authors: ross js. BMC Res Notes. 2017 Jul 28;10(1):350. doi: 10.1186/s13104-017-2687-5. BMC Res Notes. 2017. PMID: 28754150 Free PMC article.

10

Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.

Miller JE, Wilenzick M, Ritcey N, Ross JS, Mello MM. Miller JE, et al. Among authors: ross js. BMJ Open. 2017 Dec 5;7(12):e017917. doi: 10.1136/bmjopen-2017-017917. BMJ Open. 2017. PMID: 29208616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,700 results

Search Page

Filters